Evidence map›Paper›PMID 33419265›Full record

ArticleMicroorganisms2020

Comparative Gut Microbiome Differences between Ferric Citrate and Calcium Carbonate Phosphate Binders in Patients with End-Stage Kidney Disease.

Ping-Hsun Wu, Po-Yu Liu, Yi-Wen Chiu, Wei-Chun Hung, Yi-Ting Lin, Ting-Yun Lin, Szu-Chun Hung, Rachel Ann Delicano, Mei-Chuan Kuo, Chun-Ying Wu

Open access · goldAbstract read
In one paragraph

Article in Microorganisms, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 26 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Analysis of CRISPR-Cas Loci and their Targets in Levilactobacillus brevis.Interdisciplinary sciences, computational life sciences · 2023
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Ping-Hsun WuDivision of Nephrology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 807, Taiwan.ORCID 0000-0003-1021-8161
Po-Yu LiuDepartment of Internal Medicine, National Taiwan University College of Medicine, Taipei 106, Taiwan.ORCID 0000-0003-1290-0850
Yi-Wen ChiuDivision of Nephrology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
Wei-Chun HungDepartment of Microbiology and Immunology, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
Yi-Ting LinGraduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan.ORCID 0000-0002-5833-0040
Ting-Yun LinDivision of Nephrology, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, School of Medicine, Tzu Chi University, Hualien 970, Taiwan.
Szu-Chun HungDivision of Nephrology, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, School of Medicine, Tzu Chi University, Hualien 970, Taiwan.
Rachel Ann DelicanoInstitute of Surgical Sciences, Uppsala University, 75185 Uppsala, Sweden.ORCID 0000-0001-9236-2591
Mei-Chuan KuoDivision of Nephrology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
Chun-Ying WuInstitute of Biomedical Informatics, Medical College, National Yang-Ming University, Taipei 112, Taiwan.ORCID 0000-0001-5053-1801
Kaohsiung Medical University · TWTzu Chi University · TWNational Taiwan University · TWNational Yang Ming Chiao Tung University · TWUppsala University · SE

Funding

Kaohsiung Medical University KMU-Q108024Kaohsiung Medical University KMU-TP104PR25Kaohsiung Medical University KMU-TP104PR26Kaohsiung Medical University Chung-Ho Memorial Hospital KMUH104-4M05Kaohsiung Medical University Chung-Ho Memorial Hospital KMUH105-5R15Kaohsiung Medical University Chung-Ho Memorial Hospital KMUH106-6R17Ministry of Science and Technology, Taiwan MOST 105-2628-B-037-005-MY2Ministry of Science and Technology, Taiwan MOST 106-2314-B-037-054Ministry of Science and Technology, Taiwan MOST 107-2314-B-037-104
6 · The paper itself

Abstract

Gut dysbiosis in patients with chronic kidney disease (CKD) may induce chronic inflammation and increase morbidity. Phosphate-binding agents, generally used in patients with CKD, may potentially change the composition of the gut microbiota. This study aimed to compare the microbiota composition in hemodialysis patients treated with ferric citrate or calcium carbonate. The stool microbiota was investigated in hemodialysis patients treated with ferric citrate (

Indexed as

calcium carbonateferric citratehemodialysismicrobiomephosphate binders

Identifiers

PMID33419265
PMCPMC7767080
OpenAlexW3113927004

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.